[Date Prev] | [Thread Prev] | [Thread Next] | [Date Next] -- [Date Index] | [Thread Index] | [List Home]
Subject: Proposed UOML TC IPR Policy
Dear
all: By
this week, there is a proposed subject of UOM IPR Policy, while welcome all of
you have the comments on it. Proposed UOML
TC IPR
Policy
[Specification
of the IPR Mode under which the TC will operate.] RAND Mode: 1.
Except
where a Licensee has a separate, signed agreement under which the Essential
Claims are licensed to such Licensee on more favorable terms and conditions than
set forth in this section (in which case such separate signed agreement shall
supersede this Limited Patent License), each Obligated Party in this TC hereby
covenants that, it will grant to any
complete conforms of calling UOML standard: a nonexclusive, worldwide,
non-sublicensable, perpetual patent license (or an equivalent non-assertion
covenant) under its Essential Claims covered by its Contribution Obligations or
Participation Obligations without payment of royalties or fees, to make, have
made, use, market, import, offer to sell, and sell, and to otherwise distribute
Licensed Products directly or indirectly that implement such specification. Such
license need not extend to features of a Licensed Product that are not required
to comply with the Normative Portions of such specification. For the sake of
clarity, the rights set forth above include the right to directly or indirectly
authorize a third party to make unmodified copies of the Licensee's Licensed
Products and to license (optionally under the third party's license) the
Licensee's Licensed Products, within the scope of, and subject to the terms of,
the Obligated Party's license. 2.
Any
Docbase providers, i.e. makers of software which implements UOML, shall be
charged a fix percentage of the revenue generated by adopting UOML in total, as
the authorized expenses for all correlation patents, regardless the mount of the
patent involved. Regards
Pine
|
[Date Prev] | [Thread Prev] | [Thread Next] | [Date Next] -- [Date Index] | [Thread Index] | [List Home]